Chemistry
Atazanavir
100%
Lamivudine
83%
Abacavir
83%
Lipid
33%
Antiretroviral
33%
Concentration
33%
Ritonavir
16%
Once Daily
16%
Safety
16%
Point Group T
16%
Resistance
16%
RNA
16%
Neuroscience
Atazanavir
100%
Suppression
83%
Abacavir/Lamivudine
66%
HIV
50%
Protease Inhibitor
33%
RNA
16%
Ritonavir
16%
Lamivudine
16%
Abacavir
16%
Pharmacology, Toxicology and Pharmaceutical Science
Atazanavir
100%
Abacavir Plus Lamivudine
66%
HIV
50%
Lipid
33%
Adverse Event
16%
Lamivudine
16%
Proteinase Inhibitor
16%
RNA
16%
Ritonavir
16%
Abacavir
16%
Incidence
16%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus
50%
Lipid Profile
33%
Retrospective Study
33%
Trough Concentration
33%
Immune Reconstitution
16%
Abacavir
16%
Lamivudine
16%
Ritonavir
16%
CD4 Lymphocyte Count
16%
Incidence
16%
Immunology and Microbiology
Human Immunodeficiency Virus
50%
Trough Concentration
33%
CD4 Lymphocyte Count
16%
Blood Plasma
16%
Immune Reconstitution
16%
Incidence
16%